Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study
Genes · 02.06.2024 · 15 (6) · 729
DOI: 10.3390/genes15060729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 02.06.2024. Verfasst von Xiuzhi Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical …. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Esophageal Neoplasms, Gastrointestinal Microbiome, Genome-Wide Association Study. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Guangzhou.
Abstract (Originalsprache)
Background
Unbalances in the gut microbiota have been proposed as a possible cause of esophageal cancer (ESCA), yet the exact causal relationship remains unclear.
Purpose
To investigate the potential causal relationship between the gut microbiota and ESCA with Mendelian randomization (MR) analysis.
Methods
Genome-wide association studies (GWASs) of 207 gut microbial taxa (5 phyla, 10 classes, 13 orders, 26 families, 48 genera, and 105 species) and 205 gut microbiota metabolic pathways conducted by the Dutch Microbiome Project (DMP) and a FinnGen cohort GWAS of esophageal cancer specified the summary statistics. To investigate the possibility of a mediation effect between the gut microbiota and ESCA, mediation MR analyses were performed for 1091 blood metabolites and 309 metabolite ratios.
Results
MR analysis indicated that the relative abundance of 10 gut microbial taxa was associated with ESCA but all the 12 gut microbiota metabolic pathways with ESCA indicated no statistically significant association existing. Two blood metabolites and a metabolite ratio were discovered to be mediating factors in the pathway from gut microbiota to ESCA.
Conclusion
This research indicated the potential mediating effects of blood metabolites and offered genetic evidence in favor of a causal correlation between gut microbiota and ESCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer…
- State Key Laboratory of Oncology in South China, Department of Minimally Invasive Intervention, Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Ce…
- State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cance…
Förderung
- Science and Technology Program of Guangzhou
Zitieren
APA
Li, X., Xu, B., Yang, H., & Zhu, Z. (2024). Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study. Genes, 15(6), 729. https://doi.org/10.3390/genes15060729
Vancouver
Li X, Xu B, Yang H, Zhu Z. Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study. Genes. 2024;15(6):729. doi:10.3390/genes15060729
BibTeX
@article{Li2024,
author = {Li, Xiuzhi and Xu, Bingchen and Yang, Han and Zhu, Zhihua},
title = {Gut Microbiota, Human Blood Metabolites, and Esophageal Cancer: A Mendelian Randomization Study},
journal = {Genes},
year = {2024},
volume = {15},
number = {6},
pages = {729},
doi = {10.3390/genes15060729}
}
EUVIMED